本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

203.77
+0.42000.21%
盤後203.770.00000.00%19:51 EDT
成交量:137.87萬
成交額:2.79億
市值:436.75億
市盈率:-22.84
高:206.36
開:204.98
低:197.81
收:203.35
52周最高:224.31
52周最低:42.18
股本:2.14億
流通股本:1.85億
量比:1.07
換手率:0.75%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
淨資產收益率:-79.09%
總資產收益率:-30.12%
市淨率:16.76
市盈率(LYR):-34.25

資料載入中...

2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/17

重要事件披露

Form 8-K - Current report
2026/04/16

重要事件披露

Form 8-K - Current report
2026/04/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/15

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/04/13

重要事件披露

Form 8-K - Current report
2026/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities